| Imaging of liver tumors using surface-enhanced Raman scattering nanoparticles C Andreou, V Neuschmelting, DF Tschaharganeh, CH Huang, ... ACS nano 10 (5), 5015-5026, 2016 | 162 | 2016 |
| PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy D Zamarin, JM Ricca, S Sadekova, A Oseledchyk, Y Yu, ... The Journal of clinical investigation 128 (4), 1413-1428, 2018 | 146 | 2018 |
| Pre-existing immunity to oncolytic virus potentiates its immunotherapeutic efficacy JM Ricca, A Oseledchyk, T Walther, C Liu, L Mangarin, T Merghoub, ... Molecular therapy 26 (4), 1008-1019, 2018 | 143 | 2018 |
| Folate-targeted surface-enhanced resonance Raman scattering nanoprobe ratiometry for detection of microscopic ovarian cancer A Oseledchyk, C Andreou, MA Wall, MF Kircher Acs Nano 11 (2), 1488-1497, 2017 | 137 | 2017 |
| DNA-enabled rational design of fluorescence-Raman bimodal nanoprobes for cancer imaging and therapy S Pal, A Ray, C Andreou, Y Zhou, T Rakshit, M Wlodarczyk, M Maeda, ... Nature communications 10 (1), 1926, 2019 | 95 | 2019 |
| MUC1 aptamer targeted SERS nanoprobes S Pal, S Harmsen, A Oseledchyk, HT Hsu, MF Kircher Advanced functional materials 27 (32), 1606632, 2017 | 85 | 2017 |
| Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000–2013 A Oseledchyk, MM Leitao Jr, J Konner, RE O’Cearbhaill, D Zamarin, ... Annals of Oncology 28 (12), 2985-2993, 2017 | 79 | 2017 |
| Tissue factor-specific ultra-bright SERRS nanostars for Raman detection of pulmonary micrometastases TR Nayak, C Andreou, A Oseledchyk, WD Marcus, HC Wong, J Massagué, ... Nanoscale 9 (3), 1110-1119, 2017 | 50 | 2017 |
| Intraoperative hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer A Oseledchyk, O Zivanovic Oncology 29 (9), 695-695, 2015 | 37 | 2015 |
| Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus A Oseledchyk, JM Ricca, M Gigoux, B Ko, G Redelman-Sidi, T Walther, ... Oncotarget 9 (47), 28702, 2018 | 31 | 2018 |
| Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort study A Oseledchyk, RL Gennarelli, MM Leitao Jr, CA Aghajanian, A Iasonos, ... Cancer medicine 7 (6), 2280-2287, 2018 | 27 | 2018 |
| Approach to the sonographic evaluation of fetal ventriculomegaly at 11 to 14 weeks gestation G Manegold-Brauer, A Oseledchyk, A Floeck, C Berg, U Gembruch, ... BMC pregnancy and childbirth 16, 1-8, 2016 | 26 | 2016 |
| Surface-enhanced resonance raman scattering nanoprobe ratiometry for detecting microscopic ovarian cancer via folate receptor targeting C Andreou, A Oseledchyk, F Nicolson, N Berisha, S Pal, MF Kircher Journal of visualized experiments: JoVE, 2019 | 16 | 2019 |
| Impact of extended primary surgery on suboptimally operable patients with advanced ovarian cancer A Oseledchyk, LE Hunold, MR Mallmann, CM Domröse, A Abramian, ... International Journal of Gynecologic Cancer 26 (5), 2016 | 13 | 2016 |
| Multiplexed molecular imaging with surface enhanced resonance Raman scattering nanoprobes reveals immunotherapy response in mice via multichannel image segmentation C Andreou, K Plakas, N Berisha, M Gigoux, LE Rosch, R Mirsafavi, ... Nanoscale horizons 7 (12), 1540-1552, 2022 | 10 | 2022 |
| Total or subtotal colectomy in patients undergoing surgery for primary or recurrent epithelial ovarian cancer A Oseledchyk, A Abramian, C Kaiser, M Debald, C Domröse, N Kiefer, ... Oncology Research and Treatment 37 (9), 448-454, 2014 | 10 | 2014 |
| Preoperative MRI in patients with locoregional recurrent breast cancer: Influence on treatment modalities A Oseledchyk, C Kaiser, L Nemes, M Döbler, A Abramian, ... Academic Radiology 21 (10), 1276-1285, 2014 | 7 | 2014 |
| Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients A Oseledchyk, ML Gemignani, QC Zhou, A Iasonos, R Elahjji, Z Adamou, ... International Journal of Gynecologic Cancer 31 (2), 2021 | 5 | 2021 |
| 21-Gene Oncotype DX® Recurrence-Score benefits and application in elderly breast cancer patients ED Chiru, CG Kuhar, A Oseledchyk, C Kurzeder, M Vetter Journal of Geriatric Oncology 13 (8), S18-S19, 2022 | 3 | 2022 |
| Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience ED Chiru, CG Kuhar, A Oseledchyk, A Schötzau, M Javier-González, ... Translational Oncology 36, 101724, 2023 | 2 | 2023 |
